- Home
- BW vs GNLX Comparison
BW vs GNLX Comparison
Compare BW & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BW
- GNLX
- Stock Information
- Founded
- BW 1867
- GNLX 2001
- Country
- BW United States
- GNLX United States
- Employees
- BW N/A
- GNLX N/A
- Industry
- BW Building Products
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- BW Industrials
- GNLX Health Care
- Exchange
- BW Nasdaq
- GNLX Nasdaq
- Market Cap
- BW 119.1M
- GNLX 128.0M
- IPO Year
- BW N/A
- GNLX 2023
- Fundamental
- Price
- BW $2.05
- GNLX $3.51
- Analyst Decision
- BW Strong Buy
- GNLX Strong Buy
- Analyst Count
- BW 1
- GNLX 5
- Target Price
- BW $5.00
- GNLX $16.20
- AVG Volume (30 Days)
- BW 1.9M
- GNLX 85.7K
- Earning Date
- BW 08-11-2025
- GNLX 08-07-2025
- Dividend Yield
- BW N/A
- GNLX N/A
- EPS Growth
- BW N/A
- GNLX N/A
- EPS
- BW N/A
- GNLX N/A
- Revenue
- BW $724,905,000.00
- GNLX N/A
- Revenue This Year
- BW N/A
- GNLX N/A
- Revenue Next Year
- BW $8.02
- GNLX N/A
- P/E Ratio
- BW N/A
- GNLX N/A
- Revenue Growth
- BW 48.90
- GNLX N/A
- 52 Week Low
- BW $0.22
- GNLX $1.95
- 52 Week High
- BW $2.99
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- BW 77.66
- GNLX 51.78
- Support Level
- BW $1.40
- GNLX $3.26
- Resistance Level
- BW $1.83
- GNLX $4.07
- Average True Range (ATR)
- BW 0.18
- GNLX 0.24
- MACD
- BW 0.04
- GNLX 0.01
- Stochastic Oscillator
- BW 95.65
- GNLX 46.15
About BW Babcock & Wilcox Enterprises Inc.
Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.